Overview of the management of HER2-low breast cancer patients
What is HER2 low in breast cancer?
Biological behaviour of HER2-low BC is dependent on HR expression
Clinical and molecular characteristics of HER2-low/zero early stage triple-negative breast cancer
HER2-Low Breast Cancer: DESTINY or Good Science?
The exciting new field of HER2-low breast cancer
Latest news in HER2-low breast cancer
Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate
Investigating the influence of HER2 low status in LBC
Findings indicate HER2-low and HER2-negative breast cancer are biology indistinct
What is HER2 Testing in Breast Cancer? | Dr Kiley Loh
HER2 Testing Explained: What’s New in 2024?
A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast Cancer
Highlights in HER2-low breast cancer at SABCS 2022
HER2 Positive, Negative or Low? Breast Cancer Updates in 2023
HER2 Low
HER2-low status as a therapeutic target in advanced breast cancer
Dr Rimm on Unmet Needs in Distinguishing Between HER2-Low and HER2-Ultralow Breast Cancer
Understanding HER2-Low Breast Cancer: New Insights and Treatment Options
ADCs for the treatment of HER2-low breast cancer
